Works from 2024
A Refractory Case of Catastrophic Antiphospholipid Syndrome (CAPS), Shanti Timilsina MD, Matthew Mahoney MD, Kidus Kebede MD, Abhay K. Jella MD, Salman Waheeduddin MD, and Joaquin Solis MD (Poster)
Sjogren’s Induced Splenic Atrophy Leading to Overwhelming S. Pneumoniae Bacteremia and Purpura Fulminans, Daniel Jabr DO, Navedeep Kaur DO, Hector Roman-Perez MD, Daniel Strama DO, and Daniel Grahf MD (Poster)
Relevance of Adalimumab product attributes to patient experience in the Biosimilar Era: A narrative review, Jessica R. Allegretti, Jessica H. Brady, Ann Wicker, et al. (Article)
Sarcoidosis-lymphoma syndrome and CVID: Finding the zebra and overcoming health disparity barriers, Emma C. Williams and Andrea A. Pappalardo (Article)
Works from 2023
Ankylosing spondylitis case, Gina Budjak (Oral/Podium Presentation)
Coronary artery dissection and myocarditis caused by eosinophilic granulomatosis with polyangiitis (EGPA): A case report, Vidhyalakshmy Vivek, Sumeet Yadav, Hariprasad R. Korsapati, et al. (Article)
Long-term efficacy and safety of Upadacitinib in patients with rheumatoid arthritis: Final results from the BALANCE-EXTEND Open-Label Extension Study, Alan Kivitz, Alvin F. Wells, Juan I. Vargas, et al. (Article)
AB1118 Effect of apremilast on psoriatic disease domains stratified by extent of skin involvement in patients with psoriatic arthritis, Alvin F. Wells, L Teng, S Colgan, et al. (Abstract)
OP0225 Evaluation of response to adjuvanted recombinant zoster vaccination in patients with rheumatoid arthritis receiving upadacitinib: Results from a randomized trial sub-study, K Winthrop, J Klaff, Alvin F. Wells, et al. (Abstract)
Rheumatic tamponade! Massive pericardial effusion leading to a new diagnosis of rheumatoid arthritis, Ali Hasnie, M. Fuad Jan, Suhail Q. Allaqaband, et al. (Abstract)
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as biomarkers in axial spondyloarthritis: Observational studies from the program to understand the longterm outcomes in spondyloarthritis registry, Rouhin Sen, Emmeline Kim, Ruth J. Napier, et al. (Article)
Works from 2022
Baseline disease activity predicts achievement of cDAPSA treatment targets with apremilast: Phase 3 results in DMARD-naive patients with psoriatic arthritis, Philip J. Mease, Arthur Kavanaugh, Alexis Ogdie, et al. (Article)
Telemedicine and psoriatic arthritis: Best practices and considerations for dermatologists and rheumatologists, Alice B. Gottlieb, Alvin F. Wells, and Joseph F. Merola (Article)
Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naive patients, Alvin F. Wells, Christopher J Edwards, Alan J Kivitz, et al. (Article)
Ankylosing spondylitis, Abdul Salman Mohammed and Lindsay N. Moy (Book Chapter)
Gout, Sangili Chandran and Ahja D. Steele (Book Chapter)
Works from 2021
Anti-Synthetase Syndrome vs Rheumatoid Arthritis: The real culprit in a case of ILD, Bonit Gill and Allan Goldman (Poster)
Bilateral interstitial keratitis as the presenting manifestation of systemic lupus erythematosus in a child, Nausheen Abbas, Marez Megalla, Lucy Y Zhang, et al. (Article)
Efficacy of long-term treatment with once-daily baricitinib 2 mg in patients with active rheumatoid arthritis: Post hoc analysis of two 24-week, phase III, randomized, controlled studies and one long-term extension study, Alvin F. Wells, Bochao Jia, Li Xie, et al. (Article)
Insulin resistance is associated with central pain in patients with fibromyalgia, Miguel A Pappolla, Laxmaiah Manchikanti, Kenneth Candido, et al. (Article)
Works from 2020
Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY, Vibeke Strand, Namita Tundia, Alvin Wells, et al. (Article)
Reasons for hospitalization and in-hospital mortality in adult systemic lupus erythematosus, Augustine M Manadan, Soumyasri Kambhatla, Estefania Gauto-Mariotti, et al. (Article)
Coronary artery disease (CAD) risk factor analysis in an age-stratified hospital population with systemic lupus erythematosus (SLE), Dennis J Levinson, Ashraf Abugroun, Hussein Daoud, et al. (Article)
De novo inflammatory bowel disease in patients on IL-1 inhibitor therapy for rheumatologic diseases, Saad Hashmi, Ramier Lehne, Ryan T. Hoff, et al. (Abstract)
Development of inflammatory bowel disease (IBD) following the use of biologic treatment for rheumatologic diseases: A review of the Food and Drug Administration Adverse Event Reports System (FAERS), Saad Hashmi, Ryan Hoff, and Eli Ehrenpreis (Abstract)
Works from 2019
Raynaud's phenomenon manifesting as progressive abnormal MRI bone marrow signal in the toes, Mason A. Brown, Douglas Handley, and Andrew Simon (Article)
Works from 2015
Factors Associated With Time to Diagnosis in Fibromyalgia, Gabriel Chodick, Daliah Weitzman, Yael Bar-On, Varda Shalev, and Howard Amital (Supplement)
Works from 2005
Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population, Cai Lei, Zhang Dongqing, Shi Yeqing, et al. (Article)